Jenny Nij Bijvank

MSC.

20142020

Research output per year

If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

4-aminopyridine is not just a symptomatic therapy, it has a neuroprotective effect – Yes

Strijbis, E. M. M., Nij Bijvank, J. A. & Killestein, J., 1 Jan 2020, (Accepted/In press) In : Multiple Sclerosis Journal.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Diagnosing and quantifying a common deficit in multiple sclerosis: Internuclear ophthalmoplegia

Nij Bijvank, J. A., van Rijn, L. J., Balk, L. J., Tan, H. S., Uitdehaag, B. M. J. & Petzold, A., 14 May 2019, In : Neurology. 92, 20, p. e2299-e2308

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
Open Access

Saccadic fatigability in the oculomotor system

Nij Bijvank, J. A., van Rijn, L. J., Kamminga, M., Tan, H. S., Uitdehaag, B. M. J., Petzold, A. & Balk, L. J., 15 Jul 2019, In : Journal of the Neurological Sciences. 402, p. 167-174

Research output: Contribution to journalArticleAcademicpeer-review

Treatment of internuclear ophthalmoparesis in multiple sclerosis with fampridine: A randomized double-blind, placebo-controlled cross-over trial

Kanhai, K. M. S., Nij Bijvank, J. A., Wagenaar, Y. L., Klaassen, E. S., Lim, K., Bergheanu, S. C., Petzold, A., Verma, A., Hesterman, J., Wattjes, M. P., Uitdehaag, B. M. J., van Rijn, L. J. & Groeneveld, G. J., 1 Jun 2019, In : CNS Neuroscience and Therapeutics. 25, 6, p. 697-703

Research output: Contribution to journalArticleAcademicpeer-review

Open Access